Paxman AB (publ) Stock Nasdaq Stockholm
Equities
SE0009806284
Medical Equipment, Supplies & Distribution
Sales 2024 * | 292M 27.5M 37.65M | Sales 2025 * | 401M 37.77M 51.71M | Capitalization | 871M 82.02M 112M |
---|---|---|---|---|---|
Net income 2024 * | 34M 3.2M 4.38M | Net income 2025 * | 84M 7.91M 10.83M | EV / Sales 2024 * | 2.84 x |
Net cash position 2024 * | 42M 3.96M 5.42M | Net cash position 2025 * | 97M 9.14M 12.51M | EV / Sales 2025 * | 1.93 x |
P/E ratio 2024 * |
25.4
x | P/E ratio 2025 * |
10.4
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 35.76% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Paxman
CEO | Chief Executive Officer | 41 | 16-12-19 |
Director of Finance/CFO | 44 | 20-02-29 | |
Emma Thornhill
DFI | Director of Finance/CFO | 39 | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Björn Littorin
BRD | Director/Board Member | 77 | 16-11-30 |
Chairman | 70 | 16-11-30 | |
Maria Bech
BRD | Director/Board Member | 56 | 16-12-19 |
1st Jan change | Capi. | |
---|---|---|
-5.12% | 182B | |
-4.31% | 103B | |
-5.61% | 66.94B | |
+10.33% | 46.73B | |
-7.78% | 45.14B | |
+5.82% | 41.57B | |
+16.99% | 30.48B | |
+14.00% | 24.26B | |
-5.83% | 23.58B |